Kevin Weinstein

Azara Healthcare LLC is a leading provider of population health solutions for standalone and networks of physician practices, chcs, pcas and hccns. The company is based in Burlington, MA. The company's main focus is to improve patient care and close care gaps by conducting targeted outreach programs utilizing patient information already contained and curated within drvs. Azara Healthcare also offers modules that help better integrate with the healthcare ecosystem and provide more extensive care. The company was founded in 2011. Jeffrey A. Brandes has been the CEO of the company since 2011.

Azara Healthcare LLC is a leading provider of population health solutions for standalone and networks of physician practices, chcs, pcas and hccns. The company is based in Burlington, MA. The company's main focus is to improve patient care and close care gaps by conducting targeted outreach programs utilizing patient information already contained and curated within drvs. Azara Healthcare also offers modules that help better integrate with the healthcare ecosystem and provide more extensive care. The company was founded in 2011. Jeffrey A. Brandes has been the CEO of the company since 2011.

Fibroblast, Inc. designs, develops, and operates a software-as-a-service based referral management platform. Its platform fixes the broken referral process by empowering providers with the tools needed to actively manage referrals and it eliminates network leakage and maps referral patterns in real-time. The company was founded by Scott Vold and Andrew Albert in 2011 and is headquartered in Chicago, IL.

Fibroblast, Inc. designs, develops, and operates a software-as-a-service based referral management platform. Its platform fixes the broken referral process by empowering providers with the tools needed to actively manage referrals and it eliminates network leakage and maps referral patterns in real-time. The company was founded by Scott Vold and Andrew Albert in 2011 and is headquartered in Chicago, IL.

Renalogic, Inc. provides actionable solutions to reduce underwriting risks and get ahead of hidden chronic kidney disease. The company is based in Phoenix, AZ. The company offers dialysis cost containment and solutions to proactively fight the health and financial impact of chronic kidney disease (CKD). Renalogic partners with health plans to identify and manage CKD risks, protect plan assets, and reverse the progression of the disease. Kevin Weinstein has been the CEO of the company since 2021.

Renalogic, Inc. provides actionable solutions to reduce underwriting risks and get ahead of hidden chronic kidney disease. The company is based in Phoenix, AZ. The company offers dialysis cost containment and solutions to proactively fight the health and financial impact of chronic kidney disease (CKD). Renalogic partners with health plans to identify and manage CKD risks, protect plan assets, and reverse the progression of the disease. Kevin Weinstein has been the CEO of the company since 2021.

Renalogic, Inc. provides actionable solutions to reduce underwriting risks and get ahead of hidden chronic kidney disease. The company is based in Phoenix, AZ. The company offers dialysis cost containment and solutions to proactively fight the health and financial impact of chronic kidney disease (CKD). Renalogic partners with health plans to identify and manage CKD risks, protect plan assets, and reverse the progression of the disease. Kevin Weinstein has been the CEO of the company since 2021.

Fibroblast, Inc. designs, develops, and operates a software-as-a-service based referral management platform. Its platform fixes the broken referral process by empowering providers with the tools needed to actively manage referrals and it eliminates network leakage and maps referral patterns in real-time. The company was founded by Scott Vold and Andrew Albert in 2011 and is headquartered in Chicago, IL.

Renalogic, Inc. provides actionable solutions to reduce underwriting risks and get ahead of hidden chronic kidney disease. The company is based in Phoenix, AZ. The company offers dialysis cost containment and solutions to proactively fight the health and financial impact of chronic kidney disease (CKD). Renalogic partners with health plans to identify and manage CKD risks, protect plan assets, and reverse the progression of the disease. Kevin Weinstein has been the CEO of the company since 2021.